Bloomberg write..
Mydecine Innovations says the FDA has cleared it to proceed with a government funded trial of whether MYCO-001, a psilocybin compound, can help people quit smoking.
- Psilocybin is the psychedelic compound commonly found in so-called magic mushrooms
- Mydecine said the study is “the first time in 50 years the US government has funded a study evaluating a psychedelic compound for therapeutic use”
- CEO said the company prepares to submit the IND for phase 2b trial
- Says the investigator initiated trial is funded by a near $4m grant from the National Institutes of Health
- Trial aims to determine if psilocybin increases …
